DCGI approves dapagliflozin for heart failure

The US Food and Drug Administration has warned the general public and healthcare professionals against serious toxicity in sanitiser products containing methanol.

Generic drug maker Emcure Pharmaceuticals has launched India’s first generic version of sucroferric oxyhydroxide indicated for the control of increased serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

The Hyderabad-based biotechnology firm Bharat Biotech has received the nod from the Drug Controller General of India for conducting phase I and II human clinical trials for India’s first COVID -19 vaccine candidate, code-named as COVAXIN.

Delhi is preparing to set up its first plasma bank intended for the treatment of COVID-19 patients, announced the State Chief Minister Arvind Kejriwal on Monday.

Swiss-hygiene technology provider Livinguard Technologies has rolled out the world’s first virus deactivating face mask in India. The anti-microbial mask that claimed to be effective in not only giving protection from the virus but also help destroying SARS CoV2.

Continued spike in daily new cases—at 18,552 in the last 24 hours– has taken the Indian COVID-19 tally 5,08,953 as on Friday.